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Metastasisofbreastcancerisamultistepprocessthatrequires
cancer cells to invade stroma at the primary site, gain access
to vasculature, survive in the circulation, extravasate into the
parenchymaofthesecondarysite,andsurviveandproliferate
at the secondary site. During each of these steps, the
microenvironment surrounding the cancer cells is believed
to be an active participant. The cancer microenvironment
also varies during the metastatic process. At the primary
tumor in the breast, invasive cancer cells are surrounded by
ﬁbroblasts, extracellular matrix (ECM), cellular constituents
of the vasculature, inﬂammatory/immune cells, and adipose
tissue. Metastasizing cancer cells are exposed to a completely
diﬀerent microenvironment within the circulatory system.
The cancer microenvironment at the secondary site is, again,
very diﬀerent from the microenvironment of the breast and
varies depending on the sites of metastasis. At the primary
and metastatic sites, the interaction between tumor cells
and their surrounding milieu is reciprocal; the tumor cells
inﬂuence the stroma and vice versa, ultimately fueling tumor
progression. The papers in this issue discuss the dynamics
of the interactions of tumor cells and their microenviron-
ment, detailing how tumor cells manipulate their milieu
and, conversely, how the reactive tumor microenvironment
inﬂuences tumor cell plasticity, invasion, metastasis, and
cancer therapy.
Z. I. Khamis et al. provide a thorough summary of the
roles of the tumor stroma and tumor microenvironment in
the various steps involved in the metastatic process, as well
as in the development of breast cancer in their paper “Active
roles of tumor stroma in breast cancer metastasis.” The authors
discuss research ﬁndings related to the contribution of vari-
ous constituents of the tumor microenvironment, including
inﬂammatory cells, ﬁbroblasts, extracellular matrix, and
blood vessels, in the metastatic process. They also include a
discussion of the signaling pathways utilized by cancer cells
to modify the stroma and ECM. This review serves as an
excellent overview for this issue.
Two papers in this issue discuss the cancer cells them-
selves and how characteristics or functions of the cancer
cells inﬂuence the tumor microenvironment. Just as the
microenvironment signals to the cancer cells, the cancer cells
alter the microenvironment to promote tumor progression
and metastasis. J. E. Chu and A. L. Allan in their paper
“The role of cancer stem cells in the organ tropism of breast
cancer metastasis: a mechanistic balance between the “seed”
and the “soil?”” have exhaustively summarized the role of the
cancer stem cells in determining the organ tropism exhibited
by breast cancer cells. Given the fact that metastasis is an
ineﬃcient process, the authors make a compelling case for
cancer stem cells to be the rare population that is equipped
with the necessary armamentarium of traits to successfully
metastasize. The paper summarizes the hierarchical role
of cancer stem cells within the various subtypes of breast
cancer and the phenotypic and functional signatures of
breast cancer stem cells. It also puts into perspective the
origin of cancer stem cells and their role in conditioning the
premetastaticniche.Theauthorsalsoprovideadetailedanal-
ysisofthemicroenvironmentofthevariousmetastaticniches
encountered by metastatic breast cancer cells, speciﬁcally
the bone, brain, lungs, liver, and lymph nodes. The paper2 International Journal of Breast Cancer
concludes with a stimulating discussion on the contribution
of cancer stem cells to therapeutic resistance taking into
account the interactions of the cancer stem cells with the
microenvironment.
The review by J. Alsarraj and K. W. Hunter, “Bro-
modomain-containing protein 4: a dynamic regulator of
breast cancer metastasis through modulation of the extracel-
lular matrix”, is focused on the activity of bromodomain-
containing protein 4 (BRD4) in breast cancer cells. BRD4
functions as an inherited susceptibility gene for breast cancer
progression and metastasis and regulates the transcription of
select genes through epigenetic mechanisms. Multiple ECM
genes are regulated by BRD4 that may lead to changes in the
overall structureof the surrounding environment or alter the
cell-matrix interactions to promote breast cancer invasion
and metastasis.
The roles of estrogen receptor (ER) signaling and sig-
naling through Toll-like receptors (TLR) in the crosstalk
and interactions of breast cancer cells with the tumor
microenvironment are the topics of another two papers
in this issue. Hormones play a critical role in directing
breast cancer progression. Speciﬁcally, ER signaling is one
of the critical and complex determinants of breast cancer
metastasis. S. S. Roy and R. K. Vadlamudi have provided an
integrated picture of this speciﬁc signaling in the paper “Role
of estrogen receptor signaling in breast cancer metastasis”. They
emphasize the importance of ER-coregulatory proteins and
their misexpression in promoting metastasis of ER-positive
breast cancer cells. They have discussed possible therapeutic
targets to block ER-driven metastasis. Most signiﬁcantly, this
paper brings to notice the importance of deﬁning alternative
signaling pathways. Speciﬁcally, multiple signaling pathways
in addition to estrogen signaling are involved in activating
ERs. Hence, combination therapies using both endocrine
and nonendocrine agents that block these diﬀerent pathways
may have better therapeutic eﬀects and may delay metastasis.
D. Bhattacharya and N. Yusuf discuss the data regarding
TLR expression in breast cancer and its role in inﬂamma-
t i o na n dc e l ls u r v i v a li nt h et u m o rm i c r o e n v i r o n m e n ti n
“Expression of Toll-like receptors on breast tumors: taking a
Toll on tumor microenvironment.” The immune system is
intricately involved in the process of tumor progression and
metastasis and can play key roles in both tumor promotion
and tumor suppression. TLRs are critical for innate and
adaptive immunity and are expressed on inﬂammatory cells
surrounding the tumor. Recent studies have identiﬁed many
TLRs expressed by tumor cells that may promote growth
and immune evasion. This has led to the emergence of TLR
signaling as a potential target for the treatment of various
tumors.
Oneofthemostcommonsitesforthemetastasisofbreast
cancer is to bone. In accordance with this, four papers focus
on breast cancer metastasis to bone. B. Y. Reddy et al. put
into perspective the role of the microenvironment of the
bone in breast cancer metastasis in “The microenvironmental
eﬀect in the progression, metastasis, and dormancy of breast
cancer: a model system within bone marrow.” The heteroge-
neous composition of the bone microenvironment not only
facilitates the growth of breast cancer cells but also supports
andprotectsthetumorcells.Thereisabidirectionalcrosstalk
between the cells comprising the bone microenvironment
and the metastatic breast cancer cells. While modulation
of macrophage function can cause immune suppression,
the release of inﬂammatory cytokines by adipocytes can
stimulatetumorcellinvasion,andtheexpressionofSDF-1by
themyoﬁbroblastsacceleratestumorcellgrowth.Thecontri-
bution of mechanical stress in impacting tumor cell survival,
elicitation of angiogenesis, and inﬂuencing drug delivery is
elegantly summarized. This paper also discusses the role
of microenvironment-derived cytokines, chemokines, and
miRNA in inducing epithelial-mesenchymal changes and
inﬂuencing cancer cell quiescence.
D. M. Sosnoski et al. present their ﬁndings on the
inﬂuence of metastases on the levels of a variety of cytokines
and growth factors in the bone in their research article
“Changes in cytokines of the bone microenvironment during
breast cancer metastasis.” Using a xenograft model of breast
cancer metastases to bone, they demonstrate that the pres-
ence of the breast cancer cells in bone changes the normal
levels of speciﬁc cytokines. Cytokines are important for
bone remodeling, hematopoietic processes, and homeostatic
balance in the bone. Therefore, by altering cytokine levels
in the bone, metastatic breast cancer manipulates the bone
microenvironment.
A complementary perspective on the dynamic dialogue
between the stroma and the tumor cells, which impacts
metastasis of tumor cells to bone, is provided by E. Bevilac-
qua et al. in “RKIP suppresses breast cancer metastasis to
the bone by regulating stroma-associated genes.” This focuses
on the metastasis suppressor, Raf Kinase Inhibitory Protein
(RKIP), and its ability to inﬂuence the tumor microenvi-
ronment in the bone. RKIP inhibits breast cancer invasion,
intravasation, and bone metastasis via the induction of
miRNA let-7, resulting in suppression of the chromatin-
remodeling factor HMGA2 and modulation of epithelial to
mesenchymal plasticity. The use of a savvy, interdisciplinary
approach involving expression arrays from breast cancer
patients yielded a deeper understanding of key regulators
of genes that form the bone metastasis signature of cancer
cells, putting the spotlight on RKIP as a critical regulator of
the tumor milieu and impacting the ability of tumor cells to
establish bone metastases.
The bone microenvironment is a fertile soil for metas-
tasis with multiple regulatory molecules aﬀecting growth.
Accumulating evidence supports the notion that hedgehog
signaling plays a role in breast cancer metastasis to bone. In
“Thehedgehogpathwayconditionsthebonemicroenvironment
for osteolytic metastasis of breast cancer,” S. Das et al. discuss
our current understanding of how the hedgehog signaling
pathway alters the bone microenvironment to promote
metastaticbreastcancergrowth.Hedgehoginhibitorsmaybe
a viable option for the treatment and/or prevention of breast
cancer metastasis to bone.
Finally, J. W. Rostas and D. L. Dyess have provided
the surgeon’s perspective of current surgical management
of breast cancer in “Current operative management of breast
cancer:anageofsmallerresectionsandbiggercures.”Consider-
ationofthetumormicroenvironmentisanemergingfrontierInternational Journal of Breast Cancer 3
in the treatment of breast cancer. The surgeon’s primary
focus with breast-conserving surgery is obtaining tumor-
free surgical margins, but there is a question as to whether
residual stromal changes in the breast may aﬀect local
recurrence.Theauthorsemphasizethatsurgicalintervention
is currently the best hope for deﬁnitive cure of breast cancer;
however, advances in the treatment of breast cancer as a
systemic disease are needed to facilitate long-term cures.
Patient-speciﬁc molecular diagnosis and the development
of targeted chemotherapeutic agents are future hopes for
improved survival and will oﬀe rt h es u r g e o na no p p o r t u n i t y
to be more focused and allow easier management of the
disease.
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